Peking University Third Hospital (Peking University Third Clinical Medical College)

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Screening of Malignant Hyperthermia Susceptible Individuals

Recruiting

Conditions: Malignant Hyperthermia

First Posted Date: 2022-06-02

Last Posted Date: 2022-06-02

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 50

Registration Number: NCT05402839

Locations: 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China

Accuracy and Safety of Coplanar Template Assistance for Head and Neck Biopsies.

Conditions: Head and Neck Neoplasms

First Posted Date: 2022-05-31

Last Posted Date: 2022-05-31

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 30

Registration Number: NCT05396183

Locations: 🇨🇳
Department of Radiation Oncology of Peking university third hospital, Beijing, Beijing, China

3DPCT Combined With CT Guided RISI in the Treatment of Thoracic Malignant Tumors

Not Applicable

Recruiting

Conditions: Thoracic Cancer
3D Printing Coplanar Template
Radioactive Iodine-125 Brachytherapy
Nuclear Radiation Effects

Interventions: Radiation: Radioactive seed brachytherapy

First Posted Date: 2022-04-28

Last Posted Date: 2023-12-20

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 30

Registration Number: NCT05351268

Locations: 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China

Safety and Efficacy of SBRT in the Treatment of Thoracic Malignant Tumors at Different Sites

Recruiting

Conditions: Safety and Efficacy
Radiotherapy
Thoracic Cancer

Interventions: Radiation: stereotactic body radiation therapy

First Posted Date: 2022-04-27

Last Posted Date: 2023-12-27

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 120

Registration Number: NCT05349552

Locations: 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China

Analgesia in Minimally Invasive Direct Coronary Artery Bypass Grafting: Programmed Intermittent Bolus Infusions of Erector Spinae Plane Block Versus Paravertebral Block

Not Applicable

Completed

Conditions: Regional Anesthesia
Surgery
Anesthesia, Local

Interventions: Drug: Ropivacaine

First Posted Date: 2022-04-11

Last Posted Date: 2025-01-08

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 140

Registration Number: NCT05320718

Locations: 🇨🇳
Department of Anesthesiology,Peking University Third Hospital, Beijing, Beijing, China
🇨🇳
Peking University Third Hosptial, Beijing, China

China Gender-affirming Hormone Therapy Study

Recruiting

Conditions: Transgender
Gender Incongruence

Interventions: Drug: GAHT for transgender men
Drug: GAHT for transgender women

First Posted Date: 2022-04-08

Last Posted Date: 2024-11-07

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 240

Registration Number: NCT05318755

Locations: 🇨🇳
Peking University Third Hospital, Peking, Beijing, China

Effect of NMN (Nicotinamide Mononucleotide) on Polycystic Ovary Syndrome

Not Applicable

Recruiting

Conditions: Polycystic Ovary Syndrome

Interventions: Other: Placebo
Dietary Supplement: NMN intervention

First Posted Date: 2022-03-31

Last Posted Date: 2023-05-31

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 120

Registration Number: NCT05305677

Locations: 🇨🇳
Peking University Third Hospital, Beijing, China

Regulation and Mechanism of New Compound Functional Ingredients in Infants

Conditions: Oligosaccharide
Sialic Acid

Interventions: Dietary Supplement: The infants who drank milk powder were given a dietary intervention four months before

First Posted Date: 2022-03-25

Last Posted Date: 2022-03-25

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 180

Registration Number: NCT05297006

Locations: 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
🇨🇳
Peking University First Hospital, Beijing, China

Evaluation of 0.05% CsA and 0.1% FK506 Eye Drops in Ocular GVHD Treatment

Phase 4

Completed

Conditions: Graft Versus Host Disease in Eye

Interventions: Drug: tacrolimus
Drug: Cyclosporine

First Posted Date: 2022-03-24

Last Posted Date: 2022-03-24

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 89

Registration Number: NCT05294666

Locations: 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China

NP-Supported Multidisciplinary Diabetes Management During Perioperative Period

Not Applicable

Conditions: Diabetes

Interventions: Other: NP-Supported Multidisciplinary Diabetes Management

First Posted Date: 2022-03-23

Last Posted Date: 2022-03-23

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 170

Registration Number: NCT05293015

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy